Status | Study |
Not yet recruiting |
Study Name: Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET Condition: Ovarian Hyperstimulation Syndrome Date: 2017-02-20 Interventions: Drug: Triptorelin for Injection |
Not yet recruiting |
Study Name: Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome Condition: Ovarian Hyperstimulation Syndrome Date: 2016-07-14 Interventions: Drug: bromocriptine Patients i |
Recruiting |
Study Name: Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response Condition: Ovarian Hyperstimulation Syndrome Hypercoagulability Date: 2016-02-25 Interventions: Other: COAGO blood samples for haemostasis and hormonal data |
Recruiting |
Study Name: The Influence of Timing of Cabergoline Initiation on Prevention of OHSS Condition: Ovarian Hyperstimulation Syndrome Date: 2015-11-24 Interventions: Drug: Late Cabergoline 0.5mg C |
Not yet recruiting |
Study Name: The Letrozole Administration During Luteal Phase Condition: Ovarian Hyperstimulation Syndrome Date: 2015-08-20 Interventions: Drug: Letrozole used after ooc |
Withdrawn |
Study Name: Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) Condition: Ovarian Hyperstimulation Syndrome Date: 2015-03-13 Interventions: Drug: cetrorelix (cetrotide) 0 |
Not yet recruiting |
Study Name: Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients Condition: Ovarian Hyperstimulation Syndrome Date: 2014-07-23 |
Not yet recruiting |
Study Name: Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS Condition: Ovarian Hyperstimulation Syndrome Date: 2014-07-23 Interventions: Drug: recombinant LH recombinant LH twice/day for 10 days from pick up |
Completed |
Study Name: Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS Condition: Ovarian Hyperstimulation Syndrome Date: 2013-08-07 Interventions: Drug: letrozole letrozole from |
Not yet recruiting |
Study Name: Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS Condition: Ovarian Hyperstimulation Syndrome Date: 2013-03-16 Interventions: Drug: hCG Adjuvant low dose hC |